Treatment of High-risk Myelodysplastic Syndrome
Myelodysplastic syndrome (MDS) is a kind of hematological malignancies, characterized by malignant clones in hematopoietic stem cells. The treatment mainly focused on epigenetic treatment, chemotherapy, stem cell transplantation and new drugs. This article summarized all these kinds of treatments.
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Magazine House of Cancer Research on Prevention and Treatment
2020-12-01
|
| Series: | Zhongliu Fangzhi Yanjiu |
| Subjects: | |
| Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2020.20.0412.htm |
| _version_ | 1818923979956551680 |
|---|---|
| author | LI Shijun QI Junyuan |
| author_facet | LI Shijun QI Junyuan |
| author_sort | LI Shijun |
| collection | DOAJ |
| description | Myelodysplastic syndrome (MDS) is a kind of hematological malignancies, characterized by malignant clones in hematopoietic stem cells. The treatment mainly focused on epigenetic treatment, chemotherapy, stem cell transplantation and new drugs. This article summarized all these kinds of treatments. |
| first_indexed | 2024-12-20T02:18:03Z |
| format | Article |
| id | doaj.art-ffdaaffb233141c79bbbb805c007e386 |
| institution | Directory Open Access Journal |
| issn | 1000-8578 1000-8578 |
| language | zho |
| last_indexed | 2024-12-20T02:18:03Z |
| publishDate | 2020-12-01 |
| publisher | Magazine House of Cancer Research on Prevention and Treatment |
| record_format | Article |
| series | Zhongliu Fangzhi Yanjiu |
| spelling | doaj.art-ffdaaffb233141c79bbbb805c007e3862022-12-21T19:56:54ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85781000-85782020-12-014712996100210.3971/j.issn.1000-8578.2020.20.04128578.2020.20.0412Treatment of High-risk Myelodysplastic SyndromeLI Shijun0QI Junyuan1Department of Hematology, Tianjin Fourth Central Hospital, 300140 Tianjin, ChinaGCP, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science, 300020 Tianjin, ChinaMyelodysplastic syndrome (MDS) is a kind of hematological malignancies, characterized by malignant clones in hematopoietic stem cells. The treatment mainly focused on epigenetic treatment, chemotherapy, stem cell transplantation and new drugs. This article summarized all these kinds of treatments.http://html.rhhz.net/ZLFZYJ/html/8578.2020.20.0412.htmmyelodysplastic syndromehigh-risktreatment |
| spellingShingle | LI Shijun QI Junyuan Treatment of High-risk Myelodysplastic Syndrome Zhongliu Fangzhi Yanjiu myelodysplastic syndrome high-risk treatment |
| title | Treatment of High-risk Myelodysplastic Syndrome |
| title_full | Treatment of High-risk Myelodysplastic Syndrome |
| title_fullStr | Treatment of High-risk Myelodysplastic Syndrome |
| title_full_unstemmed | Treatment of High-risk Myelodysplastic Syndrome |
| title_short | Treatment of High-risk Myelodysplastic Syndrome |
| title_sort | treatment of high risk myelodysplastic syndrome |
| topic | myelodysplastic syndrome high-risk treatment |
| url | http://html.rhhz.net/ZLFZYJ/html/8578.2020.20.0412.htm |
| work_keys_str_mv | AT lishijun treatmentofhighriskmyelodysplasticsyndrome AT qijunyuan treatmentofhighriskmyelodysplasticsyndrome |